Nanomedicine Market Size, Share & Trends Report

Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-942-5
  • Number of Pages: 125
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the nanomedicine market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for nanomedicine market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of nanomedicine market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Nanomedicine Market Categorization:

The nanomedicine market was categorized into four segments, namely application (Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging, Implants), indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics), molecule type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The nanomedicine market was segmented into application, indication, molecule type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The nanomedicine market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-two countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Nanomedicine market companies & financials:

The nanomedicine market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Arrowhead Pharmaceuticals develops medicines for the treatment of intractable diseases through gene silencing. It develops therapies that rely on RNA interference mechanism that knocks down target genes. It particularly focuses on the development of therapeutics for genetic disorders. It used proprietary technologies to establish a drug discovery platform. In October 2011, Arrowhead Pharmaceuticals acquired Roche’s proprietary Liposomal Nanoparticle (LNP) RNAi delivery system along with other assets.

  • Brigham and Women's Hospital incorporates Brigham and Women’s Faulkner Hospital, Brigham and Women’s Physicians Organization, and Brigham and Women’s Hospital. Brigham and Women’s Hospital provides services for nearly all medicinal fields, with more than 1,200 physicians and 150 outpatient practices. It serves patients from the U.S., New England, and 120 other countries. It was established through a merger of the Boston Hospital for Women, Peter Bent Brigham Hospital, and the Robert Breck Brigham Hospital.             

  • Nanospectra Biosciences, Inc. is a privately held company licensed by Rice University to issue U.S. patents for nanoshells and nanoshell-based products, along with nanoparticles. It focuses on the treatment of solid tumors. In 2012, it received the Investigational Device Exemption (IDE) to conduct human clinical trials for utilizing AuroLase therapy in the treatment of lung tumors. It has also received federal grants, along with funds from the Texas State Emerging Technology Fund, private investment funds, and angel investors.

  • Sanofi is a French multinational pharmaceutical company that was developed by the merging of Aventis and Sanofi-Synthélabo. The company is engaged in research, development, and commercialization of pharmaceutical drugs, comprising both prescription-based and over-the-counter medications. Sanofi operates through five global business units in the healthcare industry—General Medicines & Emerging Markets, Vaccines, Specialty Care, Consumer Healthcare, and Diabetes & Cardiovascular Units. The company has 75 manufacturing facilities across 33 countries. The company provides its healthcare solutions to over 170 countries globally.       

  • AMAG Pharmaceuticals develops solutions for the health of patients through the commercialization and development of special pharmaceutical products. It focuses on hematology, oncology, and nephrology. It also supports patients in maternal health and the preservation of newborn stem cells. AMAG also plays a major role in the development of regenerative medicines.       

  • Bio-Gate AG, a medical technology company, applies silver technology for the development of its products. This technology is utilized for evolving consumer goods, cosmetics, and industrial products. The company uses two different technologies: micro- & nanoscale silver particles and coating of final products with a layer of silver. It provides services such as product development support, antimicrobial testing, and product registration assistance.       

  • Bristol-Myers Squibb Company is a global biopharmaceutical company engaged in the development and commercialization of prescription pharmaceuticals and biologics to serve a wide range of therapeutic areas. The company provides medicines across oncology, cardiovascular, hepatitis B/C, diabetes, HIV, and veterans’ mental health & well-being. The company operates across North America, Europe, Asia, and Latin America regions.

  • Johnson & Johnson, along with its subsidiaries, deals with R&D, manufacturing, and sales of a wide range of healthcare products. It is organized across three business segments: pharmaceuticals, medical devices & diagnostics, and consumer. The medical devices and diagnostic segments offer a vast array of products and are mainly used by nurses, physicians, clinics, and hospitals. These products include insulin delivery and blood glucose monitoring products, energy, bio-surgical & general surgery products, neurological & orthopedic products, infection prevention products, disposable contact lenses, and professional diagnostic products. Its consumer segment offers products in health and personal care verticals, including beauty, skincare, nutrition, oral care, baby care, women’s health, OTC pharmaceutical products, and wellness & prevention. It has operations in more than 60 countries globally.

  • Pfizer, Inc. is a public biopharmaceutical company that offers therapies for various diseases. Its product portfolio includes solutions in preventive medicine, wellness, and disease treatment. It operates in various research areas, including cardiovascular & metabolic diseases, neuroscience & pain, immunology & inflammation, vaccines, oncology, and rare diseases. Its R&D facilities are located in Andover, Massachusetts; Cambridge, Massachusetts; Groton, Connecticut; La Jolla, California; Pearl River, New York; San Francisco, California; and St. Louis, Missouri in the United States. Additionally, the company has facilities in Cambridge and Sandwich in the UK.

  • Abbott is a biotechnology company that develops in vitro diagnostics and offers tests as well as instrument systems across blood banks, reference labs, physician offices, hospitals, and clinics worldwide. It offers solutions in hematology, immunochemistry, transfusion instruments; and reagents/tests to serve in conditions such as cancer, cardiological disorders, drugs of abuse/toxicology, fertility/pregnancy, infectious diseases, therapeutic drug monitoring, and transplant. It serves over 22,000 customers in 100 countries.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Nanomedicine Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Nanomedicine Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon